Implications of osteoblast-osteoclast interactions in the management of osteoporosis by antiresorptive agents denosumab and odanacatib.

Implications of osteoblast-osteoclast interactions in the management of osteoporosis by antiresorptive agents denosumab and odanacatib.

Item
http://www.wikidata.org/entity/Q38183262
Coupling Signals between the Osteoclast and Osteoblast: How are Messages Transmitted between These Temporary Visitors to the Bone Surface?Sclerosing bone dysplasias: leads toward novel osteoporosis treatments.The Multifaceted Osteoclast; Far and Beyond Bone Resorption.Childhood cancer chemotherapy-induced bone damage: pathobiology and protective effects of resveratrol and other nutraceuticals.A novel approach to inhibit bone resorption: exosite inhibitors against cathepsin KIs RANKL inhibition both anti-resorptive and anabolic in rheumatoid arthritis?Multiple Vertebral Osteonecroses (Kümmell's Disease) After 10 Years on Denosumab: Is Osteocyte Apoptosis to Blame?Coupling factors and exosomal packaging microRNAs involved in the regulation of bone remodelling.The effect of cathepsin K inhibitor on osteoclastic activity compared to alendronate and enamel matrix protein.Cathepsin K inhibition preserves compressive load in lumbar vertebrae of osteoporotic monkeys
P2860

Implications of osteoblast-osteoclast interactions in the management of osteoporosis by antiresorptive agents denosumab and odanacatib.

Item
http://www.wikidata.org/entity/Q38183262
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Implications of osteoblast-ost ...... ents denosumab and odanacatib.
@en
type
label
Implications of osteoblast-ost ...... ents denosumab and odanacatib.
@en
prefLabel
Implications of osteoblast-ost ...... ents denosumab and odanacatib.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P5875
P6179
P698
P921
P356
P1433
P1476
Implications of osteoblast-ost ...... gents denosumab and odanacatib
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P5875
P6179
P698
P921